Pular para o conteúdo principal
Ranking Invest

IART - Integra LifeSciences Holdings Corporation

Segmento: HealthcareIntegra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Análise Ranking Invest

Valuation estimado
$ 643.74 Mi
Valor de Mercado
$ 1.21 Bi
Sobrepreço (AV)+87.3%
IVR
0.53A companhia vale 0,53 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.29O valuation alternativo equivale a -29% do valor de mercado da companhia.
MLL
-0.29O lucro líquido dos controladores em 16 trimestres equivale a -29% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 1.04 Bi

Dívida Líquida

$ 492.77 Mi

L4T

-$ 7.24 Mi

MM4T

-0.46%

Indicadores Básicos

ROE

-0.69%

Índices de Previsibilidade

Receita Líquida

B0.04

Lucro

F2.38

Margem

F2.28

Índices de Tendência

Receita Líquida

C6.07

Lucro

G-8.91

Margem

G-9.02

Índices de Endividamento

DIV/PAT

0.47

DIV/L4T

-68.03

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.